no Antibiotics for Elective Cesarean With Low Risk of Infection
NCT ID: NCT02126228
Last Updated: 2014-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
212 participants
OBSERVATIONAL
2012-11-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity
NCT00133029
Antibiotic Prophylaxis for Elective Cesarean Section
NCT02177994
Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery
NCT03007706
Cesarean Rate in Parturients Without Neuraxial Analgesia
NCT01157325
Prophylactic Antibiotics After Cesarean
NCT03187106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With normal temperature;
* No signs of infection;
* Normal degree of cleanliness in vaginal; .Normal amniotic fluid.
Exclusion Criteria
* Premature rupture of membranes;
* Antibiotics having been applied to 3 days before cesarean;
* Having inflammation before cesarean: such as vaginitis, pelvic inflammatory disease, chorioamnionitis;
* Having infections in respiratory or urinary system before cesarean;
* Placenta previa or placental abruption;
* With medical and surgical complications;
* BMI ≥ 30kg/m2;
* Total blood loss more than 1000ml within 2 hours after cesarean
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fanzhen Hong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fanzhen Hong
Obstetrics of 2nd Hopital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
YONGPING XU, MD.PhD
Role: STUDY_DIRECTOR
Obstetrics of 2nd Hospital of Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2nd Hospital of Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Committee opinion no. 465: antimicrobial prophylaxis for cesarean delivery: timing of administration. Obstet Gynecol. 2010 Sep;116(3):791-792. doi: 10.1097/AOG.0b013e3181f68086.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2ndhsdu-ob
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.